Posts Tagged ‘SPPI’

Weekend Review: Unusual Options Trading Review (AMR, CSTR, SLV, SFI, MSFT, SPPI)

It is Saturday and we decided to go dig through the Friday options trading looking for unusual trading in the crazy world of stock options.  Some of these are probably just par for the course but two stood out as really unusual.  We outlined the options trading and gave color in the following: AMR Corporation [...]

Spectrum Slapped by FDA (SPPI)

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is getting its wings clipped this morning.  The company received a complete response letter from FDA for FUSILEV in advanced metastatic colorectal cancer.  The response noted that it did not demonstrate that FUSILEV is non-inferior to leucovorin and recommended that it meet with them to discuss options for continuing to [...]

Novavax.. No Blue Horseshoe, No Love (NVAX)

Novavax Inc. (NASDAQ: NVAX) is getting spanked this morning. The swine flu stock and flu stock is trading lower after Oppenheimer & Co. downgraded the biotechnology company after shares went above and beyond the firm;s $6.00 price target.  The rating is now “Perform” rather than “Outperform” as before.   At the 9:30 Opening Bell NVAX is [...]

PREMARKET ALERT: Spectrum Pharmaceuticals (SPPI)

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) shares are up more than 5 percent to $6.20 in early premarket trading of fewer than 2,000 shares. The FDA has given a fast-track designation for the company’s investigation of its apaziquone candidate for the treatment of non-muscle invasive bladder cancer.  — Mike Tarsala

PREMARKET ALERT: Spectrum Pharmaceuticals (SPPI)

Specrtum Pharmaceuticals (Nasdaq: SPPI) are 20%  as of 7:45 a.m. Eastern on about 3,000 shares traded.  The FDA asked for data from the company’s already completed Phase III study to support the company’s proposed labeling of its product Zevalin as a first-line consolidation therapy for treating non-Hodgkins lymphoma. No additional clinical studies have been requested. The [...]

Premarket Alert: Spectrum Pharmaceuticals (SPPI)

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) Inc. shares are down roughly 8 percent on nearly 60,000 shares traded as of 8:15 a.m. Eastern. The company announced early this morning that it will raise $21 million from institutional investors at $7.15 a share. The stock had been trading near $7.65 a share. — Mike Tarsala